Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - GB
$ 9.39
0.859 %
$ 42.5 B
Market Cap
27.62
P/E
Price Target
Average
--2.56%
Revenue Forecast
Estimate
10.07%
EBIT
Estimate
8.34%
Net Income
Estimate
43.14%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Haleon plc
Wall Street analysts predict an average 1-year price target for HLN of $9.15 , with forecasts ranging from a low of $9.15 to a high of $9.15 .
HLN Lowest Price Target
Wall Street Target
9.15 USD
-2.56%
HLN Average Price Target
Wall Street Target
9.15 USD
-2.56%
HLN Highest Price Target
Wall Street Target
9.15 USD
-2.56%
REVENUE FORECAST
Revenue Forecast Chart HLN
EBIT FORECAST
EBIT Forecast Chart HLN
NET INCOME FORECAST
Net Income Chart HLN